Finance to Functional Genomics, One Large-scale Step | GenomeWeb

When you look at John Fowler’s 18 years of financial experience, the obvious question seems to be, Why join Large Scale Biology? Instead, the real question for the company’s new president is, What took so long?

Though Fowler’s experience is all Wall Street, “I’ve actually worked with Large Scale for about 10 years,” he says. He raised money for the long-term client back in ’94, was lead manager of Large Scale’s IPO in 2000, and has been an advisor on M&A activity as well.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.